Abstract
No benefit attributable to propranolol (1000 mg/day) could be detected in a trial lasting at least 22 weeks, 6 weeks of which was double-blind placebo-controlled, in 5 chronic schizophrenic patients. The mean propranolol CSF/plasma ration was 0.08, and there was good agreement between CSF and free plasma propranolol levels. Basal plasma prolactin was slightly but insignificantly reduced by propranolol, and metoclopramide-stimulated prolactin release was unaffected. Propranolol was associated with a significant temporary increase in HVA, a non-significant rise in 5-HIAA and a significant decrease in MHPG, in the lumbar cerebrospinal fluid of 4 patients.
References
Aug 1, 1976·The Journal of Clinical Endocrinology and Metabolism·S J JuddG Smythe
Jan 1, 1977·Biochemical Society Transactions·A A Badawy, M Evans
Feb 1, 1978·Clinical Science and Molecular Medicine·J ConwayD N Middlemiss
Sep 17, 1977·Lancet·N J YorkstonH G Sergeant
Jan 14, 1978·Lancet·T HanssenP Eneroth
Jun 21, 1979·Psychopharmacology·R H BelmakerH M Van Praag
Mar 1, 1979·British Journal of Clinical Pharmacology·J D WilsonB Sheridan
May 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·G P Sheppard
Oct 1, 1979·British Journal of Clinical Pharmacology·E A TaylorD Jefferson
Aug 1, 1978·British Journal of Clinical Pharmacology·J G Kelly, D G McDevitt
Nov 1, 1978·British Journal of Clinical Pharmacology·E A TaylorP Turner
May 1, 1977·Psychological Medicine·E C JohnstoneK Mashiter
Aug 1, 1977·Acta Psychiatrica Scandinavica·B Wode-HelgodtG Sedvall
Aug 1, 1976·Psychological Medicine·D H WilesM G Gelder
Nov 1, 1976·In Vitro·G G MaulH Koprowski
Apr 1, 1975·The Journal of Experimental Zoology·M HamburghI Pesetsky
Oct 31, 1975·Science·R M Post, F K Goodwin
Aug 11, 1973·Lancet·J GaddieK N Palmer
Oct 11, 1974·Brain Research·E GarelisT L Sourkes
Oct 1, 1974·Archives of General Psychiatry·H Y MeltzerA G Frantz
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates
Sep 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·A D HarrisP J Willems
Sep 1, 1961·The Journal of Mental Science·J K WING
Citations
Aug 1, 1993·Biological Psychiatry·A L MillerJ Castiglioni
Jan 1, 1981·Pharmacology & Therapeutics·D N MiddlemissD T Greenwood
Jan 1, 1993·Pharmacology & Therapeutics·B A Ellenbroek
Mar 1, 1984·Psychiatry Research·D W HommerD P van Kammen
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·B B Sethi, S Dubé
Aug 22, 1981·Lancet·K L MalasD P van Kammen
Mar 1, 1987·Mayo Clinic Proceedings·S C Jenkins, T Maruta
Mar 1, 1983·British Journal of Clinical Pharmacology·D J KingJ Liddle
Sep 1, 1981·Journal of Clinical and Hospital Pharmacy·M Peet, R A Yates
Feb 4, 2014·Psychiatry Research·Paul J Fitzgerald
Jan 1, 1997·Journal of Psychopharmacology·F W DeakinJ S Hellewell
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M CheineK Wahlbeck
Jun 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·R Manchanda, S R Hirsch
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·M PeetR A Yates
Aug 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·C R PughR G Priest
Dec 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·D EcclestonD A Stephens